NL-OMON43003已完成不适用
The effect of CanChew®, cannabidiol (CBD) containing chewing gum on Irritable Bowel Syndrome - The CANdidate study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •* Female, only when using the contraceptive pill
- •* Adults, aged 18-65
- •* IBS, diagnosed according to the Rome III criteria
- •* More than 3 moments of pain a week with a VAS-score of 4 and higher
- •* Signed informed consent
排除标准
- •* Use of SSRIs, tramadol or tramagetic
- •* History of intestinal surgery that might interfere with the outcome of the study
- •* Female patients: currently pregnant, breast-feeding or intending to become pregnant during the study, judged by the persons self
- •* Female who is not using the contraceptive pill.
- •* Are an employee of the department of Human Nutrition at Wageningen UR, or employee of Ziekenhuis Gelderse Vallei
- •* Participate in another research study
- •* Alcohol use (male more than 14 servings a week, female more than 7 servings a week)
- •* Hypersensitivity to one of the ingredients of the chewing gum
- •* Cannabis use is from 3 months before untill the end of the study not allowed
- •* Drug use (CYP2C19 and CYP3A4) metabolised; medication will be evaluated for this by the principal and medical investigator.
研究者
相似试验
招募中
3 期
Effects of Inclusion of Cannabidiol in the Usual Treatment of Obsessive Compulsive DisorderObsessive-compulsive disorderRBR-467ksmbFaculdade de Medicina de Ribeirão Preto - Universidade de São Paulo
尚未招募
3 期
Evaluation of the effect of cannabidiol in the treatment of schizophrenic patientsSchizophrenia.SchizophreniaIRCT20210310050660N2Qazvin University of Medical Sciences40
已完成
3 期
The effect of using Cannabidiol on the severity of spasticity in MS patients with gait disordersMultiple sclerosisSpasticity in multiple sclerosis patients with gait problem.IRCT20220815055709N1Khosro Medisa Teb Company60
已完成
1 期
Effects of cannabidiol-enriched cannabis extraction product on cognitive functions and inflammatory markers in Parkinson disease.Parkinson diseaseCannabidiol enriched cannabis extraction product, Inflammatory marker, Parkinson disease, Cannabidiol, Cognitive functionTCTR20230204001Thai Traditional Medical Knowledge Fund60
已完成
2 期
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in BlepharospasmBlepharospasmBlepharospasm, Benign EssentialCBDNCT04423341Silkiss Eye Surgery12